ArticleAmerican journal of audiology2021
Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis.
Open access · greenAbstract readConsensus Statement
In one paragraph
Article in American journal of audiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations.International forum of allergy & rhinology · 2022Pooled it
- Mechanisms, prevention, and management of aminoglycoside-induced hearing loss in neonates and children: a translational review.Frontiers in pharmacology · 2026Review
- Screening and monitoring across the lifespan of an ageing cystic fibrosis population.ERJ open research · 2025Review
- Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement project.BMJ open quality · 2025Article
- Aminoglycoside-induced sensorineural hearing loss in pediatric cystic fibrosis patients: A retrospective cohort study.Heliyon · 2024Article
- What's New in Ototoxicity Management?Perspectives of the ASHA special interest groups · 2024Article
- Ototoxicity: a high risk to auditory function that needs to be monitored in drug development.Frontiers in molecular neuroscience · 2024Review
- A longitudinal community-based ototoxicity monitoring programme and treatment effects for drug-resistant tuberculosis treatment, Western Cape.The South African journal of communication disorders = Die Suid-Afrikaanse tydskrif vir Kommunikasieafwykings · 2022Article
- Mechanisms of Ototoxicity and Otoprotection.Otolaryngologic clinics of North America · 2021Review
- Ototoxicity and Noise Damage: From Preclinical Findings to Audiological Management.American journal of audiology · 2021Article
- Detecting Novel Ototoxins and Potentiation of Ototoxicity by Disease Settings.Frontiers in neurology · 2021Review
- Article
- Article
- Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment.Ear and hearingReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 15 institutions in 4 countries.
Angela C GarinisNational Center for Rehabilitative Auditory Research, VA Portland Health Care System, OR.ORCID 0000-0002-6088-6603
Gayla L PolingDepartment of Otolaryngology - Head and Neck Surgery, Division of Audiology, Mayo Clinic, Rochester, MN.ORCID 0000-0002-4132-4461
Ronald C RubensteinDivision of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University in St. Louis School of Medicine, MO.
Dawn Konrad-MartinNational Center for Rehabilitative Auditory Research, VA Portland Health Care System, OR.
Timothy E HullarNational Center for Rehabilitative Auditory Research, VA Portland Health Care System, OR.
David M BaguleyHearing Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, United Kingdom.
Holly L BurrowsAudiology and Speech Center, Walter Reed National Military Medical Center, Bethesda, MD.
Jennifer A ChisholmOtolaryngology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD.
Amy CusterDepartment of Audiology, The Ohio State University Comprehensive Cancer Hospital-Arthur G. James Cancer Hospital and Richard J. Solve Research Institute, Columbus.
Laura Dreisbach HaweSchool of Speech, Language, and Hearing Sciences, San Diego State University, CA.
Lisa L HunterCommunication Sciences Research Center, Cincinnati Children's Hospital Medical Center, OH.
Theodore K MarrasDivision of Respiratory Medicine, Toronto Western Hospital, University Health Network and University of Toronto, Canada.
Candice E OrtizAudiology and Speech Center, Walter Reed National Military Medical Center, Bethesda, MD.
Lucretia PetersenDepartment of Health and Rehabilitation Sciences, University of Cape Town, South Africa.
Peter S SteygerNational Center for Rehabilitative Auditory Research, VA Portland Health Care System, OR.ORCID 0000-0002-6103-5237
Kevin WinthropSchool of Public Health, Oregon Health & Science University, Portland.
Erika M ZettnerDepartment of Otolaryngology-Head & Neck Surgery, Division of Audiology, University of California, San Diego.
Khaya ClarkNational Center for Rehabilitative Auditory Research, VA Portland Health Care System, OR.ORCID 0000-0002-9537-0754
Michelle HungerfordNational Center for Rehabilitative Auditory Research, VA Portland Health Care System, OR.
Jay J VachhaniNational Center for Rehabilitative Auditory Research, VA Portland Health Care System, OR.
Carmen C BrewerOtolaryngology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD.
Oregon Health & Science University · USNational Institutes of Health · USVA Portland Health Care System · USWalter Reed National Military Medical Center · USCincinnati Children's Hospital Medical Center · USCreighton University · USMayo Clinic · USSan Diego State University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USUnited States Department of Defense · USUniversity Health Network · CAUniversity of California San Diego · USUniversity of Cape Town · ZAUniversity of Nottingham · GBWashington University in St. Louis · US
Funding
Clinical Analysis Of Disorders Of Hearing And BalanceZIADC000064 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI HERTZANO, RONNA · 2009 to 2025
$25.2MHAIR CELL RESPONSES TO OTOTOXIC DRUGSR01DC004555 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2001 to 2020
$6.6MSpeech Perception and Spoken Word Recognition by Children with Cochlear ImplantsR01DC000064 · NIDCD · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MIYAMOTO, RICHARD T. · 1990 to 2008
$4.4MClinical factors in aminoglycoside-induced ototoxicityR01DC016680 · NIDCD · CREIGHTON UNIVERSITY · PI STEYGER, PETER STEPHEN · 2019 to 2023
$3.3MPrevention of Ototoxicity with Effective Monitoring (POEM) Pharmacokinetic and Auditory LinkagesR01DC017867 · NIDCD · CINCINNATI CHILDRENS HOSP MED CTR · PI GARINIS, ANGELA, HUNTER, LISA LEIGH · 2020 to 2024
$3.2MTemporal Synthesis of Vestibular and Extra-Vestibular Sensory SignalsR01DC017425 · NIDCD · MASSACHUSETTS EYE AND EAR INFIRMARY · PI HULLAR, TIMOTHY E, LEWIS, RICHARD F · 2019 to 2023
$2.7MClinical Analysis Of Disorders Of Hearing And BalanceZ01DC000064 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI GRIFFITH, ANDREW J · 2001 to 2008
$1.2MEffects of Intravenous Aminoglycoside Treatments on the Cochlear and Medial Efferent Auditory System in Patients with Cystic FibrosisR21DC016128 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI GARINIS, ANGELA · 2018 to 2020
$462kHair cell responses to ototoxic drugsR56DC004555 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2007 to 2007
$385kPhysiological, Behavioral and Predictive Correlates of Ototoxicity in HumansI01RX003127 · VA · PORTLAND VA MEDICAL CENTER · PI KONRAD-MARTIN, DAWN L · 2020 to 2024
–Intramural NIH HHS Z01 DC000064Intramural NIH HHS ZIA DC000064NIDCD NIH HHS R01 DC000064NIDCD NIH HHS R01 DC004555NIDCD NIH HHS R01 DC016680NIDCD NIH HHS R01 DC017425NIDCD NIH HHS R01 DC017867NIDCD NIH HHS R21 DC016128NIDCD NIH HHS R56 DC004555RRD VA I01 RX003127
Abstract
Purpose Specific classes of antibiotics, such as aminoglycosides, have well-established adverse events producing permanent hearing loss, tinnitus, and balance and/or vestibular problems (i.e., ototoxicity). Although these antibiotics are frequently used to treat
Indexed as
Cystic FibrosisAminoglycosidesAnti-Bacterial AgentsHearingHearing TestsHumansAminoglycosidesAnti-Bacterial Agents
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.